Navigation Links
'Translational Research: From Bench to Bedside' Capitol Hill Breakfast Briefing Hosted by the Council for American Medical Innovation
Date:9/14/2009

Briefing is the second in a three-part series on "Achieving Recovery Through Discovery"

WASHINGTON, Sept. 14 /PRNewswire-USNewswire/ -- The Council for American Medical Innovation will host a breakfast briefing on Capitol Hill titled "Translational Research - From Bench to Bedside." Health policy experts will explore important changes needed to improve the process of development and approval for safe and effective drugs, biologics, medical devices and diagnostics. The Council believes a robust infrastructure for translational research that transforms clinical research into practical treatments quickly and efficiently is critical to ensuring new, life-saving medical treatments reach the market.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090325/DC89081LOGO )

This is the second in a three-part briefing series examining the role of public policy in promoting medical innovation to help our nation recover from health and economic crises. For details on other briefings, visit: www.americanmedicalinnovation.org.

WHO: Remarks by:

  • Amy Comstock Rick, CEO of the Parkinson's Action Network
  • The Honorable Patrick Kennedy, U.S. Representative (D-RI) (invited)
  • Debra Lappin, President of the Council for American Medical Innovation
  • Alan Leshner, Ph.D., President of the American Association for the Advancement of Science (AAAS)
  • Lesa Mitchell, Vice President of the Ewing Marion Kauffman Foundation

*Debra Lappin and other panelists will be available for media interviews between 10:00 and 10:30 a.m. Please contact Laura Lowery, 206-799-5604 to secure an interview.

WHERE: Rayburn House Office Building, Room B338

WHEN: Thursday, September 17, 2009

8:30 - 10:00 a.m.

RSVP: http://www.regonline.com/recoverythroughdiscovery

About the Council for American Medical Innovation

The United States faces serious challenges to maintaining its leadership position in innovation. The Council for American Medical Innovation is bringing together leaders in research, medicine, public health, academia, education, labor, and business, who are working in partnership toward a national policy agenda aimed at preserving U.S. leadership in medical innovation. American medical innovators create millions of high-paying jobs, and their discoveries are integral in the fight to cure cancer and other illnesses. The Council for American Medical Innovation views leadership in medical innovation as a key part of America's economic recovery, future prosperity and health.

For more information on the Council for American Medical Innovation, visit www.americanmedicalinnovation.org.


'/>"/>
SOURCE Council for American Medical Innovation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. ASH and EHA Jointly Announce Translational Research Training in Hematology Program
2. ASH and EHA jointly announce translational research training in hematology program
3. EAU Research Foundation organizes meeting in Amsterdam highlighting translational research results
4. Crescendo(tm), the Clinical and Translational Research Exchange, is Launched
5. Van Andel Research Institute of Michigan and Translational Genomics Research Institute of Arizona Undertake Unprecedented Alliance to Promote Science and Health
6. OnCore System Supporting Research Informatics Needs of the University of Wisconsin's Institute for Clinical and Translational Research
7. Rockefeller Universitys Center for Clinical and Translational Science funds 18 new pilot studies
8. URMC Breaks Ground for New Translational Research Institute
9. Scripps Translational Science Institute Contributes to Discovery of Predisposition Gene for Childhood Cancer
10. Temple, Fox Chase and Geisinger create Keystone Institute for Translational Medicine
11. Singapore Is One of the Fastest Growing Bioclusters in Asia; Wave of Investments in Drug Discovery and Translational Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... ... direct measurement of corrosive ions found in power plant water and steam. , ... such as turbines and boilers, leading to extensive maintenance and unplanned shutdowns. Monitoring ...
(Date:3/28/2017)... ... ... A minimally invasive porcelain veneer is increasing in popularity ... Dental Laboratories (NADL) is informing dentists about the benefits of minimally invasive dentistry, ... and technicians that create these veneers. , According to National Board for ...
(Date:3/28/2017)... Atlantic City, NJ (PRWEB) , ... March 28, ... ... annual American Camp Association’s Tri-State Camp Conference in Atlantic City March 13-16, was ... partners, and their team of professional staff discussed strategies for preventing outbreaks among ...
(Date:3/28/2017)... ... 2017 , ... Thank you to all who attended Capio Partners Winter 2017 ... was exclusive to providers and offered an opportunity to collaborate and network with healthcare ... Grand Hyatt where attendees gathered for a lively discussion on trends and issues that ...
(Date:3/27/2017)... ... March 27, 2017 , ... New patients who have sleep apnea ... with or without a referral. Sleep apnea is often left untreated because patients are ... headaches and chronic snoring. , Dr. Braasch seeks to raise awareness of sleep ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... , March 27, 2017  Cryoport, Inc. (NASDAQ: ... it intends to offer shares of common stock in ... statement on file with the Securities and Exchange Commission ... other conditions, and there can be no assurance as ... or as to the actual size or terms of ...
(Date:3/27/2017)... -- To mark the end of Save Your Vision Month, ... digital imaging solutions, will showcase Canon eye care devices during ... New York,s Jacob Javits Center from March 30 ... the American Optometric Association, is observed annually in March to ... exams. In recognition of this observance, Canon U.S.A. ...
(Date:3/27/2017)... March 27, 2017  Sophiris Bio Inc. (NASDAQ: ... a clinical late-stage biopharmaceutical company developing topsalysin (PRX302) ... today reported fourth quarter and full year 2016 ... Key Corporate Highlights: Advanced ... Cancer. During 2016, the Company reported successful results ...
Breaking Medicine Technology: